Evolving treatment strategies for management of cardiorenal syndrome

Medicine & Life Sciences

• Cardio-Renal Syndrome 100%
• Heart Failure 29%
• Brain Natriuretic Peptide 27%
• Kidney 26%
• Ultrafiltration 19%
• Dopamine 13%
• Antidiuretic Hormone Receptor Antagonists 11%
• Sodium Potassium Chloride Symporter Inhibitors 11%
• Therapeutics 10%
• Natriuretic Peptides 10%
• Phosphodiesterase Inhibitors 9%
• Drug Therapy 9%
• Hyponatremia 9%
• National Institutes of Health (U.S.) 8%
• Diuretics 8%
• Adenosine 8%
• Dyspnea 7%
• Urine 5%
• Research Personnel 5%
• Aptitude 5%
• Safety 4%
• Mortality 4%